Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis

BACKGROUND: The immune response and safety of inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines among patients with chronic hepatitis B (CHB), especially those with cirrhosis, are not clear. Therefore, this study was conducted to evaluate the efficacy and safety of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Huanhuan, Huang, Yufei, Zhong, Chunxiu, Liao, Xingmei, Tan, Wenjuan, Zhao, Siru, Guo, Liangxu, Fan, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230951/
https://www.ncbi.nlm.nih.gov/pubmed/37266421
http://dx.doi.org/10.3389/fimmu.2023.1167533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230951/
https://www.ncbi.nlm.nih.gov/pubmed/37266421
http://dx.doi.org/10.3389/fimmu.2023.1167533

Ejemplares similares